Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio M Rodrigues

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Vaccine|March 26, 2017
Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1<sub>19</sub>Mariana Vilela Rocha, Kátia Sanches Françoso, Luciana Chagas Lima, et al.
Microbes and Infection|June 27, 2006
Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus)Daniela S Rosa, Leo K Iwai, Fanny Tzelepis, et al.
Vaccine|February 23, 2010
Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimuriumDaniel Y Bargieri, Juliana A Leite, Stefanie C P Lopes, et al.
Vaccine|September 23, 2008
New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellinDaniel Y Bargieri, Daniela S Rosa, Catarina J M Braga, et al.
Infection and Immunity|January 1, 2014
Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeastElaine C Vicentin, Kátia S Françoso, Mariana V Rocha, et al.
Vaccine|July 27, 2010
A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in miceFernanda Gentil, Daniel Y Bargieri, Juliana A Leite, et al.
Infection and Immunity|August 23, 2005
CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2Adriano F S Araújo, Bruna C G de Alencar, José Ronnie C Vasconcelos, et al.
Infection and Immunity|January 31, 2014
Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodentsLais H Teixeira, Cibele A Tararam, Marcio O Lasaro, et al.
Plos One|March 5, 2013
Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3Amanda R Bitencourt, Elaine C Vicentin, Maria C Jimenez, et al.
Plos Pathogens|May 23, 2012
Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccineJosé Ronnie Vasconcelos, Oscar Bruña-Romero, Adriano F Araújo, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Vaccine|March 26, 2017
Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1<sub>19</sub>Mariana Vilela Rocha, Kátia Sanches Françoso, Luciana Chagas Lima, et al.
Microbes and Infection|June 27, 2006
Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus)Daniela S Rosa, Leo K Iwai, Fanny Tzelepis, et al.
Vaccine|February 23, 2010
Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimuriumDaniel Y Bargieri, Juliana A Leite, Stefanie C P Lopes, et al.
Vaccine|September 23, 2008
New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellinDaniel Y Bargieri, Daniela S Rosa, Catarina J M Braga, et al.
Infection and Immunity|January 1, 2014
Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeastElaine C Vicentin, Kátia S Françoso, Mariana V Rocha, et al.
Vaccine|July 27, 2010
A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in miceFernanda Gentil, Daniel Y Bargieri, Juliana A Leite, et al.
Infection and Immunity|August 23, 2005
CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2Adriano F S Araújo, Bruna C G de Alencar, José Ronnie C Vasconcelos, et al.
Infection and Immunity|January 31, 2014
Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodentsLais H Teixeira, Cibele A Tararam, Marcio O Lasaro, et al.
Plos One|March 5, 2013
Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3Amanda R Bitencourt, Elaine C Vicentin, Maria C Jimenez, et al.
Plos Pathogens|May 23, 2012
Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccineJosé Ronnie Vasconcelos, Oscar Bruña-Romero, Adriano F Araújo, et al.
Pageof 7